ELF5 modulates the estrogen receptor cistrome in breast cancer

Acquired resistance to endocrine therapy is responsible for half of the therapeutic failures in the treatment of breast cancer. Recent findings have implicated increased expression of the ETS transcription factor ELF5 as a potential modulator of estrogen action and driver of endocrine resistance, an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS Genet
Main Authors: Piggin, Catherine L., Roden, Daniel L., Law, Andrew M. K., Molloy, Mark P., Krisp, Christoph, Swarbrick, Alexander, Naylor, Matthew J., Kalyuga, Maria, Kaplan, Warren, Oakes, Samantha R., Gallego-Ortega, David, Clark, Susan J., Carroll, Jason S., Bartonicek, Nenad, Ormandy, Christopher J.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6959601/
https://ncbi.nlm.nih.gov/pubmed/31895944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pgen.1008531
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados